Curagen Corp. About
Curagen Corp. CuraGen Corporation (NASDAQ: CRGN) is a
genomics-based pharmaceutical company dedicated to improving the lives of patients
by developing novel pharmaceutical products that address unmet medical needs.
CuraGen has translated their understanding of the genome into a broad pipeline
of protein, antibody, and small molecule drugs in the areas of oncology,
inflammatory diseases, obesity
and diabetes.
CG53135 -- Oral Mucositis PXS101
-- Multiple Myeloma, Solid Tumors More
on Curagen
Key
Statistics for Curagen
Basic
Chart for Curagen